OmniComm Systems, Inc., a provider of integrated electronic data capture (EDC) solutions for clinical trials, has been selected by Amarex, a
Mid-Atlantic based Contract Research Organization (CRO), to provide the company with eClinical solutions for an upcoming Phase III trial.
The trial will be investigating the use of a medical device for wound healing. The study will be conducted at over 30 sites and will recruit up to 300 patients over the course of two years.
Amarex also joins OmniComm’s CRO Preferred Program, which will allow them to offer OmniComm’s electronic data capture solution, TrialMaster, to their clients.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.